No video visit
All states
GLP-1 weight loss in Alabama
- Visit type
- No video visit required
- Licensing
- Alabama Board of Medical Examiners
- Updated
- Licensed by
- Alabama Board of Medical Examiners
- Telehealth
- No video visit required
- Semaglutide injections
- Available
- Tirzepatide injections
- Available
- Medicaid
- Limited coverage
- Shipping
- 2–3 business days
Alabama residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — from Birmingham and Montgomery to Huntsville, Mobile, and the rural counties in between. Pallas Health pairs you with a board-certified provider licensed in Alabama who reviews your intake — by secure message in most cases — and, if appropriate, sends your prescription to a US-licensed pharmacy that ships to any Alabama address in 2–3 business days.
How telehealth prescribing works in Alabama
Alabama permits licensed providers to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth — including asynchronous review of your intake — when the standard of care is met.
Alabama requires any provider prescribing to an Alabama resident to hold an active Alabama medical license. Under Alabama's telehealth statute (Ala. Code §§ 34-24-701 through 34-24-707), a licensed provider may use telehealth to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s — including synchronous video and, in appropriate cases, asynchronous review — provided the standard of care is met and the encounter is properly documented. Every Pallas provider who treats Alabama patients holds an active Alabama medical license. GLP-1s are not controlled substances, so Alabama's separate controlled-substance telemedicine requirements do not apply — but our providers still take a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and follow up after initiation to monitor response and titrate the dose.
Medicaid & insurance in Alabama
Alabama Medicaid covers GLP-1s for type 2 diabetes with prior authorization. Weight-management indications are generally not covered, and compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Simple cash-pay pricing in Alabama
No insurance, and the same price in every Alabama ZIP code. You see your full price during intake, before you pay anything. One plan price covers your US-licensed provider, check-ins, dose adjustments and care-team messaging, with no membership fee. Medication ships free, and nothing is charged until a clinician prescribes. Cancel anytime. Your clinician helps determine which option is appropriate for you.
Compounded
- Semaglutide injectionsFrom $139
- Tirzepatide injectionsFrom $179
Brand-name
- Wegovy® injectionsFrom $499
- Zepbound® injectionsFrom $499
- Ozempic® injectionsFrom $499
- Mounjaro® injections$1,099/mo
- Wegovy® pillFrom $299
- Foundayo™ pillFrom $299
Semaglutide vs tirzepatide in Alabama
Both are once-weekly injections available to Alabama patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.
In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks — with broadly similar tolerability. That trial predates Wegovy®'s higher 7.2 mg weekly dose, which reached 18.7% average weight loss over 72 weeks in the separate STEP UP trial; separate trials do not provide a direct comparison. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
Cost and track record differ too: compounded semaglutide renews at $199 every 4 weeks versus $299 for tirzepatide (full terms in the questions below), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in Alabama — our full semaglutide vs tirzepatide comparison covers the deeper differences.
Cash-pay GLP-1 telehealth compared for Alabama
Pallas is a cash-pay telehealth service that serves every ZIP code in Alabama. Compounded semaglutide is one all-in plan price: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. That price covers your US-licensed clinician, ongoing check-ins and the medication when prescribed, with no separate membership fee. No video visit is required in Alabama.
| Service | Published price | Medication | Charged at signup |
|---|---|---|---|
| Pallas Health | $139 first month, then $199 every 4 weeks; no membership fee | Included, with your US-licensed clinician, check-ins and messaging | Nothing until a clinician prescribes |
| Ro | $149/mo membership month-to-month; $39 first month; $74/mo on a 12-month prepay | Billed separately. Brand-name only on its pricing page (Wegovy® pen from $199/mo); no compounded semaglutide price published | $39, refunded if not eligible |
| Henry Meds | From $179/mo, varies by medication and dose | Included, with provider visits and supplies | Not stated on its pricing page |
| Mochi Health | $79/mo membership; $39 first month | Billed separately. Compounded semaglutide from $60/mo, compounded tirzepatide from $90/mo | $39 due today |
Other services’ figures are quoted from their own websites on September 24, 2026; prices change often and vary by dose and plan length, and availability in Alabama varies by service. Hims & Hers is not listed because no current published price could be verified on that date. This is a factual comparison, not a ranking or an endorsement.
Four things to check before you pay any GLP-1 telehealth service
- Does the quoted price include the medication, or is it a membership billed on top of it?
- Is the company LegitScript-certified? Any website can be checked at legitscript.com.
- Are you charged before a clinician has reviewed you and prescribed?
- Does the clinician hold a Alabama license, and does the pharmacy filling the prescription hold a Alabama permit?
Cities served in Alabama
Partner pharmacies ship to every ZIP code in Alabama, including:
- Birmingham
- Montgomery
- Huntsville
- Mobile
- Tuscaloosa
- Hoover
- Auburn
- Dothan
Alabama GLP-1 questions
No. Alabama allows a licensed clinician to review your intake by secure message and prescribe without a scheduled video call. They may ask for a video visit only if your history calls for it.
Start the online intake (about 5 minutes). An Alabama-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a US-licensed pharmacy ships it to you in 2–3 business days.
Same intake as semaglutide. If appropriate, an Alabama-licensed clinician can prescribe compounded tirzepatide or FDA-approved Zepbound® or Mounjaro®, and explains which fits you.
Yes. An Alabama-licensed clinician can prescribe it for you with a documented clinical reason, and a US-licensed compounding pharmacy prepares it per patient. Brand-name Wegovy® is also available.
Yes. Alabama nurse practitioners prescribe under a written collaborative practice agreement with an Alabama physician. GLP-1s are not controlled substances, so they can be prescribed by telehealth.
Several do. Check that its clinicians are licensed in Alabama, that it uses US-licensed compounding pharmacies, and that it is LegitScript-certified. Pallas serves Alabama.
Intake takes about 5 minutes, and an Alabama-licensed clinician usually reviews it within 1 to 2 business days. If prescribed, the pharmacy ships in 2–3 business days.
Yes. Partner pharmacies ship to every Alabama ZIP code, from Birmingham and Montgomery to the smallest towns, usually in 2–3 business days. Remote addresses may take an extra day.
Several do. Check that its clinicians hold an Alabama license, that it uses US-licensed pharmacies, and that it is LegitScript-certified (the database is public). Pallas serves Alabama.
Alabama Medicaid covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
One flat cash-pay price, the same in every Alabama ZIP code, no insurance needed. It covers your clinician, check-ins and messaging, and medication ships free once prescribed.
An Alabama-licensed clinician decides after reviewing your intake. GLP-1s are generally considered at a BMI of 30 or more, or 27 or more with a condition like high blood pressure.
Wegovy®, Ozempic®, Zepbound® and Mounjaro® are FDA-approved. Compounded semaglutide and tirzepatide are made per patient by US-licensed pharmacies and are not FDA-approved. Your clinician decides.
Yes. Tell your clinician your current medication, dose and everything else you take during intake. If appropriate, they continue you at a comparable dose. Don't change a prescription on your own.
Most patients use a once-weekly injection with a very fine needle. A daily tablet is available on request. Your clinician confirms which form is appropriate for you.
Mostly stomach-related: nausea, constipation or diarrhea, usually mildest when the dose is raised slowly. They are avoided in pregnancy and with a personal or family history of medullary thyroid cancer or MEN2.
You answer health questions online in about 5 minutes. An Alabama-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a licensed pharmacy ships it in 2–3 business days.
Your first order arrives in 2–3 business days, and most patients start low and step up gradually. Your plan renews on a set schedule so refills arrive before you run out; change or cancel anytime in the portal.
Compounded semaglutide injections are $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Compounded tirzepatide injections are $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Yes. Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight management, Ozempic® and Mounjaro® for type 2 diabetes. All are cash-pay: pens from $499 first month, daily pills from $299.
Alabama Medicaid covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
Two cash-pay paths: stay on Wegovy® or Zepbound® from $499 first month, or a compounded plan from $139 first month if a licensed clinician finds it appropriate. Tell your clinician your current dose.
A decision for you and your clinician. Semaglutide costs less and has the longer track record; tirzepatide acts on two gut-hormone receptors instead of one. The comparison above covers the trials.
Pallas serves all of Alabama with one price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. No video visit is required.
Rule changes affecting Alabama
- 2026-07-27 Correction — statute and rule citations updated on four state pages: Vermont now cites 18 V.S.A. § 9361(b) (previously a nonexistent § 3053a), Ohio cites Ohio Rev. Code § 4743.09 and OAC 4731-37-01 (previously the controlled-substances chapter 4731-11), Colorado cites C.R.S. § 12-240-107 (previously § 12-240-138, the professional-entities section), and Alabama cites Ala. Code §§ 34-24-701 through 34-24-707 (previously the repealed Admin. Code ch. 540-X-15). Regulatory substance is unchanged in all four.State statute and administrative-code databases; surfaced by our automated source check (PR #45).
From our state-by-state rules tracker. Get an email when a rule changes.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.